Risk factors for progression and prognosis of primary Sjögren’s syndrome‐associated interstitial lung disease in a Chinese population
- 23 November 2020
- journal article
- research article
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 23 (12) , 1734-1740
Abstract
Objective: This study explored differences between primary Sjögren's syndrome‐associated interstitial lung disease (pSS‐ILD) patients with and without ILD progression, and analyzed the factors affecting the progression and prognosis of pSS‐ILD.Methods: This study is a retrospective cohort study which enrolled 113 pSS‐ILD patients hospitalized between 2011 and 2017.Results: The 3‐year survival rate of the pSS‐ILD patients was 91.15%, and the 5‐year survival rate was 84.07%. Univariate analysis showed that Raynaud's syndrome, hypoproteinemia, extensive lung involvement, possible usual interstitial pneumonia pattern were risk factors for the progression of ILD in patients with pSS‐ILD, and cyclophosphamide was a protective factor for the progression of ILD in patients with pSS‐ILD. Multiple logistic regression analysis showed that extensive lung involvement (odds ratio 4.143, 95% CI: 1.203‐14.267, P < .05) was an independent risk factor for the progression of pSS‐ILD. Cox hazard analysis showed that pSS‐ILD with hypoproteinemia (hazard ratio [HR] 17.758, 95% CI: 4.753‐66.340, P <‐ .05) and extensive lung involvement (HR 3.450, 95% CI: 1.419‐8.390, P < .05) were associated with worse survival of patients.Conclusion: Extensive lung involvement is an independent risk factor for the progression of ILD in patients with pSS‐ILD. Hypoproteinemia and extensive lung involvement are independent risk factors for mortality in patients with pSS‐ILD, after controlling for potentially influential variables.Keywords
This publication has 21 references indexed in Scilit:
- Clinical pulmonary involvement in primary Sjogren's syndrome: prevalence, quality of life and mortality--a retrospective study based on registry dataRheumatology, 2012
- Effect of cyclophosphamide on cytokines in patients with primary Sjögren’s syndrome-associated interstitial lung disease in South ChinaRheumatology International, 2012
- Patients with limited rheumatoid arthritis-related interstitial lung disease have a better prognosis than those with extensive diseaseRheumatology, 2010
- EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndromeAnnals of the Rheumatic Diseases, 2010
- Serum Albumin Concentration and Waiting List Mortality in Idiopathic Interstitial PneumoniaChest, 2009
- High-Resolution CT Scan Findings in Patients With Symptomatic Scleroderma-Related Interstitial Lung DiseaseChest, 2008
- Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis–associated interstitial lung disease are not predictive of disease progressionArthritis & Rheumatism, 2007
- Standardisation of spirometryEuropean Respiratory Journal, 2005
- POOR NUTRITIONAL STATUS AND INFLAMMATION: Serum Albumin: Relationship to Inflammation and NutritionSeminars in Dialysis, 2004
- Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus GroupAnnals of the Rheumatic Diseases, 2002